CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 
 

BTCY's Net Cash Flow Growth by Quarter and Year

Biotricity Inc 's Net Cash Flow results by quarter and year




BTCY Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - -2.10 5.10 2.47
III Quarter December -0.07 -4.71 11.47 0.47
II Quarter September -0.50 -4.86 -2.00 -0.82
I Quarter June 0.12 -4.60 -0.93 1.02
FY   -0.45 -16.27 13.64 3.14



BTCY Net Cash Flow third quarter 2024 Y/Y Growth Comment
Biotricity Inc in the third quarter 2024 recorded net cash outflow of $ -0.07 millions.

According to the results reported in the third quarter 2024, Biotricity Inc achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Biotricity Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2024.




BTCY Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - 106.48 % -
III Quarter December - - 2340.43 % -
II Quarter September - - - -
I Quarter June - - - -
FY   - - 334.39 % -

Financial Statements
Biotricity Inc 's third quarter 2024 Net Cash Flow $ -0.07 millions BTCY's Income Statement
Biotricity Inc 's third quarter 2023 Net Cash Flow $ -4.71 millions Quarterly BTCY's Income Statement
New: More BTCY's historic Net Cash Flow Growth >>


BTCY Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - -55.54 % 425.53 %
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - 334.39 % -




Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Biotricity Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Net Cash Flow Comment
Even if Biotricity Inc in the III. Quarter 2024 revealed net cash outflow of $ -0.07 millions, some analyst mentioned, that this are improvement compare to the -0.50 millions in the second quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Net Cash Flow growth. While Biotricity Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Net Cash Flow Comment
Although Biotricity Inc in the III. Quarter 2024 admitted net cash outflow of $ -0.07 millions, some analyst said, that current results point to slight up side in contrast to the -0.50 millions in the second quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Net Cash Flow growth. While Biotricity Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Biotricity Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -2.55 $ -7.19 $ -11.55 $ -16.27 $ -9.07
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BTCY's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BTCY's Competitors
Net Cash Flow Growth for Biotricity Inc 's Suppliers
Net Cash Flow Growth for BTCY's Customers

You may also want to know
BTCY's Annual Growth Rates BTCY's Profitability Ratios BTCY's Asset Turnover Ratio BTCY's Dividend Growth
BTCY's Roe BTCY's Valuation Ratios BTCY's Financial Strength Ratios BTCY's Dividend Payout Ratio
BTCY's Roa BTCY's Inventory Turnover Ratio BTCY's Growth Rates BTCY's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Affimed N v -3.72%$ -3.716 millions
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Vycor Medical Inc -12.95%$ -12.945 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Biolinerx Ltd -18.50%$ -18.499 millions
Innate Pharma Sa-18.82%$ -18.824 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Aeterna Zentaris Inc -22.49%$ -22.495 millions
Anaptysbio inc-24.22%$ -24.222 millions
Aclarion Inc -24.38%$ -24.381 millions
Koru Medical Systems Inc -26.57%$ -26.570 millions
Cardiol Therapeutics inc -29.12%$ -29.117 millions
Xtl Biopharmaceuticals Ltd -29.47%$ -29.471 millions
Redhill Biopharma Ltd -32.25%$ -32.252 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia Inc -46.46%$ -46.456 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com